PAMELA KUZERA: Open Payments
NPI 1336646934 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 18 payments from 11 companies in 2025. Trend: 2023 $500 · 2024 $396 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 1 | $76 |
| Novo Nordisk Inc | 4 | $65 |
| ABBVIE INC. | 3 | $55 |
| Exact Sciences Corporation | 2 | $35 |
| ACADIA Pharmaceuticals Inc | 1 | $33 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lundbeck LLC | 1 | $30 |
| Verona Pharma, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: Assure WCD, REXULTI, VRAYLAR, The Cologuard Plus Collection Kit, DAYBUE, TRELEGY ELLIPTA, Ohtuvayre, QULIPTA.
Industry payments across MI — which companies pay providers there.
